| Year |
Citation |
Score |
| 2018 |
Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, Schreiber RD. Pillars Article: IFNγ and Lymphocytes Prevent Primary Tumour Development and Shape Tumour Immunogenicity. . 2001. 410: 1107-1111. Journal of Immunology (Baltimore, Md. : 1950). 201: 827-831. PMID 30038035 |
0.652 |
|
| 2005 |
Dunn GP, Bruce AT, Sheehan KC, Shankaran V, Uppaluri R, Bui JD, Diamond MS, Koebel CM, Arthur C, White JM, Schreiber RD. A critical function for type I interferons in cancer immunoediting. Nature Immunology. 6: 722-9. PMID 15951814 DOI: 10.1038/Ni1213 |
0.538 |
|
| 2005 |
Dunn GP, Bruce AT, Sheehan KCF, Shankaran V, Uppaluri R, Bui JD, Diamond MS, Koebel CM, Arthur C, White JM, Schreiber RD. Erratum: Corrigendum: A critical function for type I interferons in cancer immunoediting Nature Immunology. 6: 852-852. DOI: 10.1038/Ni0805-852B |
0.524 |
|
| 2001 |
Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, Schreiber RD. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature. 410: 1107-11. PMID 11323675 DOI: 10.1038/35074122 |
0.69 |
|
| 2000 |
Hanson HL, Donermeyer DL, Ikeda H, White JM, Shankaran V, Old LJ, Shiku H, Schreiber RD, Allen PM. Eradication of established tumors by CD8+ T cell adoptive immunotherapy. Immunity. 13: 265-76. PMID 10981969 DOI: 10.1016/S1074-7613(00)00026-1 |
0.513 |
|
| 1998 |
Rodig S, Kaplan D, Shankaran V, Old L, Schreiber RD. Signaling and signaling dysfunction through the interferon gamma receptor. European Cytokine Network. 9: 49-53. PMID 9831186 |
0.401 |
|
| 1998 |
Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ, Schreiber RD. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proceedings of the National Academy of Sciences of the United States of America. 95: 7556-61. PMID 9636188 DOI: 10.1073/Pnas.95.13.7556 |
0.585 |
|
| Show low-probability matches. |